Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Pseudomyxoma Peritonei

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Oslo University Hospital HF, Radium, Oslo, Oslo, Norway
Contact: Study coordinator (Geir Olav Hjortland, Medical Doctor - Oncologist) · kreftstudier@ous-hf.no · +47 22934000
Contact: Principal Investigator (Geir Olav Hjortland, Medical doctor - Oncologist)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

Appendiceal Mucinous Neoplasm · Pseudomyxoma Peritonei

Abroad (travel likely)RecruitingPHASE2

Orange, United States

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis

Peritoneal Carcinomatosis · Pseudomyxoma Peritonei · Mesothelioma Peritoneum

Abroad (travel likely)Recruiting

Montpellier, France

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Pseudomyxoma Peritonei

Abroad (travel likely)Recruiting

Beijing, China

Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients

Pseudomyxoma Peritonei

Abroad (travel likely)RecruitingPHASE2

Milan, Italy